News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
679,965 Results
Type
Article (65089)
Company Profile (158)
Press Release (614718)
Multimedia
Podcasts (67)
Webinars (14)
Section
Business (182778)
Career Advice (3000)
Deals (33787)
Drug Delivery (119)
Drug Development (79153)
Employer Resources (186)
FDA (15465)
Job Trends (14761)
News (318994)
Policy (30492)
Tag
Academia (2930)
Academic (2)
Accelerated approval (6)
Adcomms (24)
Allergies (91)
Alliances (46434)
ALS (98)
Alzheimer's disease (1384)
Antibody-drug conjugate (ADC) (133)
Approvals (15463)
Artificial intelligence (292)
Autoimmune disease (24)
Automation (16)
Bankruptcy (307)
Best Places to Work (11478)
BIOSECURE Act (20)
Biosimilars (108)
Biotechnology (106)
Bladder cancer (80)
Brain cancer (28)
Breast cancer (289)
Cancer (2290)
Cardiovascular disease (178)
Career advice (2533)
Career pathing (34)
CAR-T (163)
Cell therapy (452)
Cervical cancer (22)
Clinical research (64203)
Collaboration (857)
Company closure (2)
Compensation (387)
Complete response letters (24)
COVID-19 (2676)
CRISPR (46)
C-suite (271)
Cystic fibrosis (105)
Data (2278)
Decentralized trials (2)
Denatured (28)
Depression (49)
Diabetes (265)
Diagnostics (6474)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (122)
Drug pricing (108)
Drug shortages (24)
Duchenne muscular dystrophy (93)
Earnings (64479)
Editorial (43)
Employer branding (25)
Employer resources (160)
Events (102458)
Executive appointments (780)
FDA (16837)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (786)
Gene editing (117)
Generative AI (25)
Gene therapy (320)
GLP-1 (725)
Government (4654)
Grass and pollen (6)
Guidances (146)
Healthcare (18830)
Huntington's disease (22)
IgA nephropathy (27)
Immunology and inflammation (121)
Indications (29)
Infectious disease (2819)
Inflammatory bowel disease (151)
Inflation Reduction Act (9)
Influenza (55)
Intellectual property (99)
Interviews (555)
IPO (15480)
IRA (40)
Job creations (3684)
Job search strategy (2117)
Kidney cancer (10)
Labor market (41)
Layoffs (530)
Leadership (23)
Legal (6815)
Liver cancer (76)
Lung cancer (326)
Lymphoma (150)
Machine learning (9)
Management (62)
Manufacturing (316)
MASH (73)
Medical device (12989)
Medtech (12994)
Mergers & acquisitions (18912)
Metabolic disorders (686)
Multiple sclerosis (82)
NASH (20)
Neurodegenerative disease (92)
Neuropsychiatric disorders (27)
Neuroscience (1935)
NextGen: Class of 2025 (6642)
Non-profit (4513)
Now hiring (39)
Obesity (354)
Opinion (241)
Ovarian cancer (80)
Pain (99)
Pancreatic cancer (85)
Parkinson's disease (145)
Partnered (21)
Patents (248)
Patient recruitment (115)
Peanut (50)
People (60711)
Pharmaceutical (40)
Pharmacy benefit managers (16)
Phase I (20134)
Phase II (28278)
Phase III (20833)
Pipeline (1302)
Policy (143)
Postmarket research (2584)
Preclinical (8743)
Press Release (69)
Prostate cancer (110)
Psychedelics (33)
Radiopharmaceuticals (251)
Rare diseases (382)
Real estate (6235)
Recruiting (74)
Regulatory (21181)
Reports (51)
Research institute (2518)
Resumes & cover letters (479)
Rett syndrome (5)
RNA editing (4)
RSV (41)
Schizophrenia (72)
Series A (137)
Series B (90)
Service/supplier (13)
Sickle cell disease (55)
Special edition (15)
Spinal muscular atrophy (148)
Sponsored (30)
Startups (3608)
State (1)
Stomach cancer (12)
Supply chain (60)
Tariffs (37)
The Weekly (37)
Vaccines (704)
Venture capitalists (41)
Weight loss (231)
Women's health (33)
Worklife (20)
Date
Last 7 days (906)
Last 30 days (2856)
Last 365 days (31362)
2025 (11452)
2024 (33859)
2023 (38223)
2022 (48534)
2021 (53619)
2020 (52662)
2019 (46543)
2018 (35399)
2017 (32130)
2016 (31677)
2015 (37053)
2014 (29843)
2013 (26484)
2012 (28029)
2011 (28277)
2010 (26889)
Location
Africa (945)
Alabama (56)
Alaska (7)
Arizona (192)
Arkansas (14)
Asia (40038)
Australia (7165)
California (5989)
Canada (1950)
China (511)
Colorado (264)
Connecticut (276)
Delaware (151)
Europe (93445)
Florida (902)
Georgia (213)
Hawaii (1)
Idaho (56)
Illinois (569)
India (28)
Indiana (313)
Iowa (11)
Japan (167)
Kansas (100)
Kentucky (26)
Louisiana (12)
Maine (61)
Maryland (879)
Massachusetts (4381)
Michigan (243)
Minnesota (364)
Mississippi (2)
Missouri (88)
Montana (29)
Nebraska (25)
Nevada (64)
New Hampshire (61)
New Jersey (1752)
New Mexico (29)
New York (1751)
North Carolina (1019)
North Dakota (9)
Northern California (2633)
Ohio (203)
Oklahoma (15)
Oregon (37)
Pennsylvania (1300)
Puerto Rico (13)
Rhode Island (31)
South America (1255)
South Carolina (20)
South Dakota (1)
Southern California (2253)
Tennessee (100)
Texas (892)
United States (22782)
Utah (184)
Virginia (147)
Washington D.C. (61)
Washington State (557)
West Virginia (3)
Wisconsin (65)
679,965 Results for "university of applied sciences berlin".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Funding secured for CE approval of the groundbreaking C-MIC device from Berlin Heals Holding AG
The Berlin Heals Holding AG has developed the C-MIC device, a revolutionary and life-saving treatment for patients with heart failure.
June 17, 2024
·
2 min read
Press Releases
Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer
March 19, 2025
·
4 min read
Business
Berlin Cures Expands Research Capabilities and Scientific Expertise with New Advisory Board
Berlin Cures, a biotechnology company in Phase II clinical trial for a treatment against Long COVID, appoints six distinguished scientists to a new advisory board.
April 3, 2024
·
3 min read
Press Releases
Invaio Sciences, a Flagship Pioneering Company, Appoints Magalie Guilhabert as Chief Science Officer
May 7, 2025
·
3 min read
Drug Development
Screening Completed: Berlin Cures Achieves Key Milestone in BC 007 Phase II Trial for Treatment of Long COVID
Berlin Cures announced the successful completion of patient screening for its pan-European Phase II trial of BC 007, a novel therapeutic candidate for the treatment of Long COVID.
April 23, 2024
·
2 min read
Pharm Country
Applied DNA Announces Pricing of $12 Million Public Offering
Applied DNA Sciences, Inc., a leader in PCR-based DNA technologies, announced the pricing of a public offering with gross proceeds to the Company expected to be approximately $12.0 million, before deducting placement agent fees and other estimated expenses payable by the Company.
May 28, 2024
·
5 min read
Press Releases
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
March 25, 2025
·
3 min read
Complete response letters
Applied Therapeutics Crashes After FDA Rejection of Rare Disease Drug
After extending its review period to evaluate additional submissions, the FDA ultimately denied Applied Therapeutics’ govorestat for galactosemia, citing “deficiencies” with the application. The biotech plans to meet with the regulator to discuss the best way forward for the drug.
December 2, 2024
·
3 min read
·
Tristan Manalac
Regulatory
FDA Warns Applied Therapeutics of ‘Objectionable Conditions’ in Govorestat Study
The agency’s warning letter outlines Applied Therapeutics’ failure to provide adequate information regarding the clinical trial—including a dosing error for govorestat—claims that the company said it had already addressed.
December 4, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Caris Life Sciences Appoints Eric Matthews as Chief Business Officer, Biopharma Business Development
May 8, 2025
·
2 min read
1 of 67,997
Next
